2023 Toyota Corolla Cross hybrid: Consumer shopping guide:
The EPA hasn't released fuel economy numbers for the Corolla Cross hybrid, but we expect to see estimates as high as 45 mpg city and 38 mpg highway. On our 75-mph highway fuel economy test route, we recorded 36 mpg. For more information about the Corolla Cross hybrid's fuel economy, visitDrivers familiar with the Corolla sedan will find themselves at home inside the Corolla Cross hybrid.
The dashboard layout, interior materials, and convenience features are nearly identical to the four-door model's and there's nothing fashionable about it. However, the Corolla Cross's larger dimensions create more room for passengers—particularly in the back seat—and additional space for cargo.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Toyota's global sales rise 5.1% to 4.9 mln in first half of 2023Japanese automaker Toyota Motor said on Friday it sold 5.1% more vehicles in the first half of 2023 compared with the same period a year earlier, helped by an easing of semiconductor supply constraints and especially stronger demand in Japan.
Baca lebih lajut »
2023 Toyota Sienna Long-Term Update: A bouncing third rowIts cavernous amount of space is of course delightful, but I have one particular bone to pick with the third-row seats.
Baca lebih lajut »
Teens In Stolen Toyota Corolla Strike And Injure A Bike Cop In Toronto | CarscoopsThe officer was transported to a hospital where his non-life-threatening injuries were treated car auto cars
Baca lebih lajut »
Cupra Born Sales Increased In Q2 2023 By 60% Year-Over-YearIn Q2, Seat/Cupra all-electric car sales amounted to 9,700 units, which is about 60% more than a year ago and more than 7% of the total volume.
Baca lebih lajut »
Skoda All-Electric Car Sales Reached a New Record In Q2 2023In Q2, Skoda noticeably increased its all-electric car sales - by 41% year-over-year to roughly 18,900 units - achieving the best quarterly result so far.
Baca lebih lajut »
Bristol Myers sales fall, cuts 2023 forecast as drugs face competitionDrugmaker Bristol Myers Squibb on Thursday said its second-quarter sales fell more than expected and cut its full-year forecast as two of its top drugs, blood cancer treatment Revlimid and blood thinner Eliquis, face generic competition.
Baca lebih lajut »